EIF2AK3 and neoplasm: P-Glycoprotein, whose level increases after PERK activation, pumps several intracellular drugs out of tumor cells, which in turn reduces drug-induced apoptosis of tumor cells and leads to drug resistance (Cao et al., 2021).